Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report.

MLA

Schettini, Francesco, et al. “Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case Report.” Frontiers in Oncology, vol. 12, Nov. 2022, p. 1009352. EBSCOhost, https://doi.org/10.3389/fonc.2022.1009352.

APA

Schettini, F., Seguí, E., Conte, B., Sanfeliu, E., Gonzalez-Farre, B., Jares, P., Vidal-Sicart, S., Ganau, S., Cebrecos, I., Brasó-Maristany, F., Muñoz, M., Prat, A., & Vidal, M. (2022). Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report. Frontiers in Oncology, 12, 1009352. https://doi.org/10.3389/fonc.2022.1009352

Chicago

Schettini, Francesco, Elia Seguí, Benedetta Conte, Esther Sanfeliu, Blanca Gonzalez-Farre, Pedro Jares, Sergi Vidal-Sicart, et al. 2022. “Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case Report.” Frontiers in Oncology 12 (November): 1009352. doi:10.3389/fonc.2022.1009352.